about
Evolving clinical phenotypes in HIV-associated neurocognitive disordersThe longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.Pattern of neuropsychological performance among HIV positive patients in Uganda.A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder.Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis.Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementiaTranscriptome analyses identify key cellular factors associated with HIV-1-associated neuropathogenesis in infected men.Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.A comparison of performance-based measures of function in HIV-associated neurocognitive disorders.HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda.Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder.HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairmentLongitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatusSubcortical brain atrophy persists even in HAART-regulated HIV disease.Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death.Human immunodeficiency virus-associated dementia: an evolving disease.Factors affecting brain structure in men with HIV disease in the post-HAART era.Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection.Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected menNeuroprotective therapy for HIV dementia.Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry.Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individualsNovel markers of oxidative stress in actively progressive HIV dementia.Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adultsPlatelet decline as a predictor of brain injury in HIV infection.Cohort Profile: Recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study.Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz.Neurologic disorders incidence in HIV+ vs HIV- men: Multicenter AIDS Cohort Study, 1996-2011.NeuroAIDS in AfricaMixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort studyInfluence of highly active antiretroviral therapy on persistence of HIV in the central nervous system.Longitudinal neuropsychological test performance among HIV seropositive individuals in Uganda.Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort StudyPrevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort StudyRandomized trial of minocycline in the treatment of HIV-associated cognitive impairment.HIV-associated cognitive impairment in sub-Saharan Africa--the potential effect of clade diversity.
P50
Q26859192-58D02608-1C44-4B8E-9463-1FBDA131642EQ30410418-24B871E7-CB4C-49EB-B2C5-B562C90DEA47Q30445074-FDB340AE-0A94-4BA3-89F7-74EDF3FE54FFQ30548228-F4655F41-5EE6-402A-8069-15532F0DB630Q33232505-30DE993A-AD55-4FC9-8F8C-D29C91C069CEQ33525781-3FC09916-C3E8-4705-8DDC-67CCB591282AQ33558180-3CC993F7-FB3B-4954-AE39-FA11F876340CQ33600252-C7CDC85B-CE3F-4A2F-A415-6EDE3DA98B5CQ33616224-13A18C59-70F3-4B3A-B4BA-1A93F525B610Q33624877-1231A6DD-D4FB-4422-A516-286FE819AD8BQ34103216-B22A87EA-3E1B-45FD-B112-D19137E2C688Q34135328-68B07D1B-466C-4DA3-92EC-A9C4477D18D5Q34180413-0D286659-7BAB-487D-9331-7DEF65A9D5D9Q34718216-EB21B717-EBC5-48E2-86DE-99054EB4017EQ34748660-BF15D4F6-9454-476C-B800-FAB27D8ECB4EQ34862412-60DD085D-A0DE-4407-B11D-E32EC302EB8BQ35003408-611BC01E-A2C9-4A77-B548-6A5C64B5B927Q35030103-EF220CBB-B2B1-41A0-8C28-1946AC73BA2CQ35058529-58D07FCD-CA5F-4018-BA9E-37D1371780B1Q35112016-ACC96E87-8E51-4A20-8A16-E9DF5FFD6E9CQ35159533-306764AC-8961-4EBB-A164-B415F8D20DF6Q35189591-D02AA03D-B9AE-4A8E-99DE-E18F9FC63C42Q35587294-CD16C2E0-1EDF-4B63-BB7F-810DB3CEA0A2Q35720234-4EEA8814-F85E-492E-9FD7-D27C9F254C73Q35825108-51C57B25-D021-41C7-9315-F7FBE100FB69Q35902953-91F038F9-2D7C-4878-8C33-16DD678A8590Q35972808-48538C4F-20EB-4646-A5A1-B3DEA7958937Q36162221-2ADACDE8-E523-488B-88AA-DCBCD5355774Q36320562-4A690359-3617-49D3-ABE1-54CE3EAEA7CBQ36376672-37FD4B6A-5AFE-42AD-87BF-A4E0DE8EA10CQ36406259-302577A6-052F-4C64-8574-14E93EC41D0DQ36475300-33FC267F-F81F-4C78-A12C-038A7D216080Q36547128-4DA0A9C9-7777-49CD-9545-3157E55AEE5CQ36550686-40D82DC4-7892-4B69-AD6E-20D0FCC0D68CQ36568228-40D1A6C4-2313-4496-BB40-9E3DCB6F87A6Q36597858-731B0E7C-0EDE-44BF-9BF3-FE07653E1F67Q36597909-F571AC59-2148-4E01-A556-2059B064663CQ36645145-FC7DBD87-1F30-4B00-B339-1442514FDB13Q36659385-D2C37FCF-9D83-498F-92E1-A85A725EA127Q36900074-A9689E23-AE7B-4B9D-A543-0B05FC5F3CE0
P50
name
Ned Sacktor
@en
Ned Sacktor
@nl
type
label
Ned Sacktor
@en
Ned Sacktor
@nl
prefLabel
Ned Sacktor
@en
Ned Sacktor
@nl